Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Clinical Trial of Etrolizumab for Patients with Moderately to Severely Active Crohn's Disease (Bergamot)

    A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (Bergamot)

    • Autoimmune Disorder
    • Crohn's Disease